The report “Creatinine Assay Kits Market by Type (Jaffe’s Kinetic Test, Creatinine-PAP, and ELISA), Sample (Blood, Serum, Urine, Saliva, CSF, Tissue Homogenate, Sweat) and Region (North America, Europe, Asia and RoW) - Global Forecast to 2022", The global creatinine assay kits market is expected to reach USD 245.4 Million by 2022 from USD 189.6 Million in 2017, at a CAGR of 5.3%.
Increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and advancements in biomedical research pertaining to kidney disorders are the key drivers of the global creatinine assay kits market.
Download PDF Brochure@
The objectives of this study are as follows:
# To define, describe, and forecast the global creatinine assay kits on the basis of type, type of sample, and region
# To estimate the total number of Creatinine Measurement tests conducted by type and region
# To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
# To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall market
# To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for the market leaders
# To forecast the size of the market with respect to five regions: North America, Europe, Asia, and the Rest of the World (RoW)
# To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
# To track and analyze competitive developments in the creatinine assay kits industry, such as acquisitions, agreements, product launches & upgrades, expansions, and R&D activities
In 2017, North America dominated the creatinine assay kits market
In 2017, North America dominated the market followed by Europe. The large share of North America is attributed to factors such as increasing incidence of renal disorders, rising prevalence of other chronic disorders like hypertension and diabetes (which can lead to renal dysfunction), and the implementation of favorable government initiatives to increase awareness of and encourage research pertaining to kidney diseases.
Request Sample Pages@
The creatinine assay kits market is highly fragmented with the presence of several large as well as emerging players. Prominent players in this market include Thermo Fisher Scientific (US), Merck (Germany), Abbott Laboratories (US), Abcam (UK), Quidel (US), Enzo Life Sciences (US), Cayman Chemical (US), Crystal Chem (US), Cell Biolabs (US), Genway Biotech (US), BioAssay Systems (US), Wako Pure Chemical Industries (Japan), Tulip Diagnostics (India), BioVision (US), and Arbor Assays (US).
Agreements, acquisitions, and expansions accounted for the largest share of the overall growth strategies followed by key players between 2014 and 2017.
The creatinine assay kits market is highly fragmented in nature with many big and small players.
Thermo Fisher Scientific was the leading player in the creatinine assay kits market in 2016. The leading position of the company can be attributed to its strong brand recognition, customer loyalty, and extensive product portfolio. The company has a strong geographic presence and a keen focus on increasing its reach and enhancing its distribution network. Along with its wide distribution network, the company also adopts strategies like collaborations and agreements to retain its market position.
Merck KGaA ranked second in the creatinine assay kits market in 2016. The company has strong brand recognition and a wide geographical presence. The company prominently focuses on inorganic growth strategies such as agreements, collaborations, and acquisitions to strengthen its market position. It acquired Sigma-Aldrich (US), a multinational chemical, life science, and biotechnology company, for USD 17 billion. This acquisition made the company one of the leaders in the science and technology industry and helped it enhance its product portfolio, capabilities, and geographical presence
Read More Detailed Article@
No comments:
Post a Comment